# An Integrative Genomics Approach for the Discovery of Potential Clinically Actionable Diagnostic and Prognostic Biomarkers in Colorectal Cancer

## TL;DR

This study combines gene expression and mutation data to find new biomarkers and drivers of colorectal cancer, which could improve diagnosis and prognosis.

## Contribution

The study introduces an integrative genomics approach to identify clinically actionable biomarkers by combining gene expression and somatic mutation data.

## Key findings

- A signature of somatic mutated genes was found to be transcriptionally associated with colorectal cancer.
- Differentially expressed somatic mutated genes were identified that distinguish patients who died from those who survived.
- Enrichment analysis revealed molecular networks and pathways enriched for somatic mutations.

## Abstract

Background: Despite remarkable progress in clinical management of patients and intensified screening, colorectal cancer remains the second most common cause of cancer-related death in the United States. The recent surge of next generation sequencing has enabled genomic analysis of colorectal cancer genomes. However, to date, there is little information about leveraging gene expression data and integrating it with somatic mutation information to discover potential biomarkers and therapeutic targets. Here, we integrated gene expression data with somatic mutation information to discover potential diagnostic and prognostic biomarkers and molecular drivers of colorectal cancer. Methods: We used publicly available gene expression and somatic mutation data generated on the same patient populations from The Cancer Genome Atlas. We compared gene expression data between tumors and controls and between dead and alive. Significantly differentially expressed genes were evaluated for the presence of somatic mutations and subjected to functional enrichment analysis to discover molecular networks and signaling pathways enriched for somatic mutations. Results: The investigation revealed a signature of somatic mutated genes transcriptionally associated with colorectal cancer and a signature of significantly differentially expressed somatic mutated genes distinguishing dead from alive. Enrichment analysis revealed molecular networks and signaling pathways enriched for somatic mutations. Conclusions: Integrative bioinformatics analysis combining gene expression with somatic mutation data is a powerful approach for the discovery of potential diagnostic and prognostic biomarkers and potential drivers of colorectal cancer.